JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
5.0%
1m
12.3%
3m
20.3%
all
15.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 11.4 0%
11.4
15
Company Overview

Sales
74.5 Cr
Growth: 28.5%
Profit after Tax
3.55 Cr
Growth: 17.4%
Micro Cap
37.6 Cr
P/E: 10.6x
Industry P/E: 33.2x
Fundamentals

Sales (Cr) ₹ 74.5
Growth 28.5%
EBITDA 10.2%
P/S 0.5x
Dividend 0.0%
P/E 10.6x
Book Value ₹ 10
PEG Ratio 0.4x
ROE 10.8%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)